01 Feb 2023

BIA submission to Spring Budget 2023

BIA has submitted its representation to HM Treasury for the Spring Budget 2023. 

BIA has submitted its representation to HM Treasury for the Spring Budget 2023. 

In our submission, we say:

  • The Prime Minister’s and Chancellor’s pro-innovation growth agenda and ambitions for the UK to be a science superpower are very welcome, however, recent announcements and ongoing reviews of R&D tax relief do not match this rhetoric
  • Innovative companies are living through half a decade of instability due to successive and ongoing changes to the R&D tax relief at a time when the UK should be doing everything it can to support start-ups and scale-ups
  • The halving of the SME R&D tax relief at Autumn Statement has already negatively impacted investment decisions, resulted in cancelled hiring plans and movement of investment from the UK
  • We call on the government to delay, for R&D intensive businesses, the SME R&D relief rate cut announced at Autumn Statement 2022 and also delay the refocusing of relief to UK activity announced at Autumn Statement 2021.
×
deep biotech.png

Welcome to the new BIA site!

BIA are excited to announce the soft launch of our new website!

Our team is diligently working behind the scenes to enhance your browsing experience and provide you with valuable content. During this phase, you may encounter sections that are still under construction. We kindly ask for your patience as we finalise everything.

Thank you for visiting, and we thank you for your continuous support towards BIA.